World's Best Scientists 2026 revealed!
Daniel L. Van Dyke

Daniel L. Van Dyke

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
9771
World Ranking
15703
National Ranking
6544

Overview

Daniel L. Van Dyke is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of medicine, particularly in genetics, pathology and forensic medicine, immunology, molecular biology, and hematology. Their research spans multiple aspects of chronic lymphocytic leukemia (CLL) and related hematological conditions.

The scientist has published notable work in the area of chronic lymphocytic leukemia research, lymphomas, immunodeficiency, and autoimmune disorders. Their primary research topics include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Gastrointestinal Tumor Research and Treatment
  • Advanced Breast Cancer Therapies
  • Acute Myeloid Leukemia Research
  • Glycosylation and Glycoproteins Research

Frequent publication venues for Daniel L. Van Dyke include:

  • Blood
  • Blood Cancer Journal
  • American Journal of Hematology
  • Cancer Genetics
  • Cancer Research

Collaborations feature prominently in their work. Key coauthors who have frequently contributed alongside Daniel L. Van Dyke are:

  • Neil E. Kay
  • Sameer A. Parikh
  • Susan L. Slager
  • Yucai Wang
  • Kari G. Rabe

Their recent papers illustrate a focus on CLL and related immune conditions. Examples of these publications include:

  • "CLL update 2022: A continuing evolution in care" (2022) published in Blood Reviews
  • "The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor" (2020) in Haematologica
  • "Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia" (2020) in The Oncologist
  • "Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome" (2021) in Blood Cancer Journal
  • "Defining clear cell papillary renal cell carcinoma in routine clinical practice" (2020) in Histopathology

Daniel L. Van Dyke's body of work is aligned with ongoing research efforts in hematology and oncology, with an emphasis on advancing understanding of CLL and related malignancies through genetic and immunological approaches.

Best Publications

  • DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    Naseema Gangat;Domenica Caramazza;Rakhee Vaidya;Geeta George

  • Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

    Wei Ding;Betsy R. LaPlant;Timothy G. Call;Sameer A. Parikh

  • Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region

    Daniel L. Van Dyke;Maria J. Worsham;Timothy Drumheller;Michael S. Benninger

  • RARE TRISOMY MOSAICISM DIAGNOSED IN AMNIOCYTES, INVOLVING AN AUTOSOME OTHER THAN CHROMOSOMES 13, 18, 20, AND 21: KARYOTYPE/PHENOTYPE CORRELATIONS

    Lillian Y.F. Hsu;Ming Tsung Yu;Richard L. Neu;Daniel L. Van Dyke

  • Evidence for a Turner Syndrome Locus or Loci at Xp11.2-p22.1

    Andrew R. Zinn;Vijay S. Tonk;Zhong Chen;Zhong Chen;Wendy L. Flejter

  • Clinical significance of Y chromosome loss in hematologic disease.

    Anne Wiktor;Benjamin A. Rybicki;Zhe Si Piao;Muhammad Shurafa

  • De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience

    Constantine S. Tam;Constantine S. Tam;Tait D. Shanafelt;William G. Wierda;Lynne V. Abruzzo

  • Long QT syndrome-associated mutations in intrauterine fetal death.

    Lia Crotti;David J. Tester;Wendy M. White;Daniel C. Bartos

  • Characterization of Neo-Centromeres in Marker Chromosomes Lacking Detectable Alpha-satellite DNA

    Theresa W. Depinet;Joleen L. Zackowski;William C. Earnshaw;Sara Kaffe

  • Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma.

    Gordon W. Dewald;Terry Therneau;Dirk Larson;You Kyoung Lee

  • Laboratory guideline for Turner syndrome.

    Daynna J. Wolff;Daniel L. Van Dyke;Cynthia M. Powell

  • The Spreading of X Inactivation into Autosomal Material of an X;autosome Translocation: Evidence for a Difference between Autosomal and X-Chromosomal DNA

    Wendy M. White;Huntington F. Willard;Daniel L. Van Dyke;Daynna J. Wolff

  • International Prognostic Scoring System–independent cytogenetic risk categorization in primary myelofibrosis

    Kebede Hussein;Animesh D. Pardanani;Daniel L. Van Dyke;Curtis A. Hanson

  • Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features

    Deborah A. Bowen;Timothy G. Call;Greg D. Jenkins;Clive S. Zent

  • INCIDENCE AND SIGNIFICANCE OF CHROMOSOME MOSAICISM INVOLVING AN AUTOSOMAL STRUCTURAL ABNORMALITY DIAGNOSED PRENATALLY THROUGH AMNIOCENTESIS: A COLLABORATIVE STUDY

    Lillian Y.F. Hsu;Ming Tsung Yu;Kathleen E. Richkind;Daniel L. Van Dyke

  • Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization

    Maria J Worsham;Maria J Worsham;Sandra R Wolman;Sandra R Wolman;Thomas E Carey;Thomas E Carey;Richard J Zarbo;Richard J Zarbo

  • Conventional cytogenetics in myelofibrosis: literature review and discussion.

    Kebede Hussein;Daniel L. Van Dyke;Ayalew Tefferi

  • Preclinical validation of fluorescence in situ hybridization assays for clinical practice

    Anne E Wiktor;Daniel L Van Dyke;Peggy J Stupca;Rhett P Ketterling

  • A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.

    Daniel L. Van Dyke;Tait D. Shanafelt;Timothy G. Call;Clive S. Zent

  • Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck.

    Richard P. Pearlstein;Michael S. Benninger;Thomas E. Carey;Richard J. Zarbo

Frequent Co-Authors

Neil E. Kay
Neil E. Kay Mayo Clinic
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
Tait D. Shanafelt
Tait D. Shanafelt Stanford University
Susan L. Slager
Susan L. Slager Mayo Clinic
Kari G. Rabe
Kari G. Rabe Mayo Clinic
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Gordon W. Dewald
Gordon W. Dewald Mayo Clinic
Thomas E. Carey
Thomas E. Carey University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to diverse online degree and career options in the health and life sciences fields. For those aiming to advance into leadership roles, the best doctorate of healthcare administration programs can equip professionals with advanced management and policy-making skills, preparing graduates for top roles in healthcare organizations.

If your interests center on pharmaceuticals, online pharmd programs for non pharmacists offer a flexible path to a high-demand credential, even for those without a pharmacy background. These programs blend scientific coursework with practical pharmaceutical training.

For students passionate about fitness, health promotion, or athletic performance, a sports science degree online explores anatomy, physiology, and movement science—foundations for careers in athletic training, wellness coaching, and exercise physiology.

Similarly, an accelerated kinesiology degree online enables quick entry into growing fields like rehabilitation, occupational therapy, and health education.

Exploring these online programs can help you expand your knowledge, boost your credentials, and tailor your career in the vibrant and evolving world of biology, biochemistry, and related health sciences.

Best Scientists Citing Daniel L. Van Dyke

Trending Scientists